Head-to-head comparison
Levity vs NowPatient
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Levity is a telehealth weight loss provider dispensing FDA-approved branded GLP-1 medications only, with no compounded options.
$1,199/mo (brand-name) sema · $1,299/mo (brand-name) tirz · Verified July 2026
Marked down on: Premium pricing, roughly 1,199 to 1,599 per month
FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.
Desk Score
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
$1,349/mo (brand-name) sema · $1,069/mo (brand-name) tirz · Verified July 2026
Marked down on: Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
Levity takes this head-to-head with the higher Desk Score, 76/100 (C) against 59/100 (C) for NowPatient. NowPatient still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Levity
76/100
C
NowPatient
59/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Levity | NowPatient |
|---|---|---|
| Semaglutide | $1,199/mobrand-name$1,199/mo (all doses, bundle, brand-name) | $1,349/mobrand-name$1,349/mo (brand Wegovy) |
| Tirzepatide | $1,299/mobrand-name$1,299/mo (all doses, bundle, brand-name) | $1,069/mobrand-name$1,069/mo (brand Mounjaro, promotional rate) |
| Coverage | 36 states | Not listed on NowPatient's site (checked July 2026) |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Yes |
| Best for | Patients wanting all-inclusive branded GLP-1 pens and willing to pay premium cash prices. | Brand-name GLP-1 access without a compounded route. |
| Desk Score | 76/100C | 59/100C |
The verdict
Desk pick — LevityLevity takes this head-to-head with the higher Desk Score, 76/100 (C) against 59/100 (C) for NowPatient. NowPatient still holds its ground where its strengths line up with yours.
Choose Levity if…
Patients wanting all-inclusive branded GLP-1 pens and willing to pay premium cash prices.
$1,199/mo (brand-name) sema · $1,299/mo (brand-name) tirz · 36 states
FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.
Choose NowPatient if…
Brand-name GLP-1 access without a compounded route.
$1,349/mo (brand-name) sema · $1,069/mo (brand-name) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Levity · NowPatient.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Levity
- CoreAge Rx vs NowPatient
- Amazon One Medical vs Levity
- Gala Health vs NowPatient
- Gala Health vs Levity
- LillyDirect Foundayo vs NowPatient
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.